Cite
Cerebral Small Vessel Disease Burden for Bleeding Risk during Antithrombotic Therapy: Bleeding with Antithrombotic Therapy 2 Study.
MLA
Tanaka, Kanta, et al. “Cerebral Small Vessel Disease Burden for Bleeding Risk during Antithrombotic Therapy: Bleeding with Antithrombotic Therapy 2 Study.” Annals of Neurology, vol. 95, no. 4, Apr. 2024, pp. 774–87. EBSCOhost, https://doi.org/10.1002/ana.26868.
APA
Tanaka, K., Miwa, K., Koga, M., Yoshimura, S., Kamiyama, K., Yagita, Y., Nagakane, Y., Hoshino, H., Terasaki, T., Okada, Y., Yakushiji, Y., Takahashi, S., Ueda, T., Hasegawa, Y., Shiozawa, M., Sasaki, M., Kudo, K., Tanaka, J., Nishihara, M., & Yamaguchi, Y. (2024). Cerebral Small Vessel Disease Burden for Bleeding Risk during Antithrombotic Therapy: Bleeding with Antithrombotic Therapy 2 Study. Annals of Neurology, 95(4), 774–787. https://doi.org/10.1002/ana.26868
Chicago
Tanaka, Kanta, Kaori Miwa, Masatoshi Koga, Sohei Yoshimura, Kenji Kamiyama, Yoshiki Yagita, Yoshinari Nagakane, et al. 2024. “Cerebral Small Vessel Disease Burden for Bleeding Risk during Antithrombotic Therapy: Bleeding with Antithrombotic Therapy 2 Study.” Annals of Neurology 95 (4): 774–87. doi:10.1002/ana.26868.